HOME >> BIOLOGY >> NEWS
Vaccine Kills Spreading Cancer In Animal Model

Johns Hopkins scientists have developed a vaccine that, in mice, can alert the immune system to the presence of stray cancer cells and significantly reduce their blood-borne spread.

"Metastatic cancer, or cancer that is spreading from its site of origin, is among the toughest stages of cancer to treat," says Hongxiu Ji, M.D., postdoctoral fellow. "Our findings suggest cancer vaccines could be an important tool for preventing and treating the spread of cancers."

Giving the vaccine prior to a tail vein injection of cancer cells prevented development of metastatic lung tumors in eight of 10 mice, while all the mice in two control groups that received cancer cells but no vaccine developed tumors. A second test against established lung cancer showed that the vaccine completely eliminated tumors in 50 percent of mice.

Ji presents her results, funded by the National Institutes of Health and the Richard W. TeLinde endowment, at this week's meeting of the American Society of Gene Therapy in Seattle.

The vaccine takes advantage of a protein, E7, produced by the human papilloma virus and commonly found in cervical cancers and their metastatic cancers. To make the vaccine, scientists altered vaccinia, a common virus, to include a gene for E7 and a molecular signal. The vaccine infects cells in the body, causing them to make E7, and the molecular signal triggers a chain reaction that calls E7 to the immune system's attention. This leads to an immune system attack on all cells that contain the protein--including the cancer cells.

To test whether the vaccine is effective against metastatic cervical cancer, Ji and her colleagues developed a line of tumor cells by genetically altering mouse lung cells to include E7. This made the cells similar to cervical cancer cells. She then showed that a tail vein injection of the cancer cells could cause lung tumors in mice in two weeks.

Tests showed the vaccine could
'"/>

Contact: Michael Purdy
mpury@jhmi.edu
(410)955-8725
Johns Hopkins Medical Institutions
2-Jun-1998


Page: 1 2 3

Related biology news :

1. Hope Clinic of Emory Vaccine Center receives CDC contract
2. Vaccines against foodborne disease on horizon
3. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
4. Vaccine technique shows potential against common form of lung cancer
5. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
6. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
7. Vaccine prevents stroke in rats
8. Vaccine puts blood-sucking ticks off their food
9. Vaccine protects against fatal West Nile complication
10. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
11. Vaccine controls AIDS in monkeys, researchers report in Science

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vaccine Kills Spreading Cancer Animal Model

(Date:8/17/2015)... 17, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... for Q4 2015. The new marketing campaign is being ... Amplitude Marketing Group ( http://amplitudemarketing.com/ ) and TPMG ( ... leader in retail driven marketing and brand awareness and ...
(Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
(Date:9/2/2015)... Sept. 2, 2015 Australian prostate cancer technology ... Australian science prize recognising ,outstanding, science that uses its ... globally launch a novel prostate cancer diagnostic test known ... level consortium taking out the peer-reviewed Australian Museum Eureka ... This prize is awarded for ground ...
(Date:9/2/2015)... Israel , September 2, 2015 ... the intent of the National Institute of Allergy and Infectious ... (NIH) within the Department of Health and Human Services (HHS), ... in the United States in the ... universal flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's ... entire waste to energy process and continue to contribute to the sustainability of ... Temarry’s Waste to Energy process has been operating at their Mexico facility, Recicladora ...
(Date:9/1/2015)... (PRWEB) , ... September 02, 2015 , ... Spirax ... new features to its eCommerce site Spirax Sarco Anytime. This platform, offering unique ... wait to place your next order? Log on to Spirax Sarco Anytime and ...
Breaking Biology Technology:Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Spirax Sarco Announces New Features to Anytime Platform 2
Cached News: